MediWound (MDWD) Cash from Investing Activities (2013 - 2026)
MediWound (MDWD) posted quarterly Cash from Investing Activities of -$23.9 million for Q4 2025, down 594.84% year-over-year from $4.8 million in Q4 2024, and down 645.58% quarter-over-quarter from $4.4 million in Q3 2025.
MediWound (MDWD) Cash from Investing Activities (2013 - 2026) Analysis & Trends
MediWound's Cash from Investing Activities history runs 13 years deep, the most recent figure standing at -$23.9 million for Q4 2025.
- In Q4 2025, Cash from Investing Activities fell 594.84% year-over-year to -$23.9 million; the TTM figure through Dec 2025 stood at -$18.0 million (down 113.77% YoY), while the FY2025 annual figure was -$18.0 million, down 113.77% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$23.9 million, down from $4.4 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $5.0 million in Q4 2023, with the low at -$26.1 million in Q2 2023.
- The 5-year median for Cash from Investing Activities is -$160000.0 (2022), against an average of -$3.5 million.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities slumped 8690.0% in 2022, then soared 130.65% in 2025.
- MediWound's Cash from Investing Activities stood at -$116000.0 in 2021, then sank by 2173.28% to -$2.6 million in 2022, then soared by 290.67% to $5.0 million in 2023, then declined by 3.98% to $4.8 million in 2024, then slumped by 594.84% to -$23.9 million in 2025.
- Business Quant data shows MDWD's Cash from Investing Activities at -$23.9 million in Q4 2025, $4.4 million in Q3 2025, and $4.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | -2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.39 Mn |
| Jun 30, 2026 | -2.39 Mn |
| Dec 31, 2025 | -23.89 Mn |
| Dec 31, 2025 | -23.89 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 4.91 Mn |
| Jun 30, 2025 | 4.91 Mn |
| Mar 31, 2025 | -3.34 Mn |
| Mar 31, 2025 | -3.34 Mn |
| Dec 31, 2024 | 4.83 Mn |
| Dec 31, 2024 | 4.83 Mn |
| Sep 30, 2024 | -14.29 Mn |
| Sep 30, 2024 | -14.29 Mn |
| Jun 30, 2024 | 2.85 Mn |
| Jun 30, 2024 | 2.85 Mn |
| Mar 31, 2024 | -1.78 Mn |
| Mar 31, 2024 | -1.78 Mn |
| Dec 31, 2023 | 5.03 Mn |
| Dec 31, 2023 | 5.03 Mn |